| Value | ₹35.32 Cr |
|---|
BSE filing, NSE: KHADIM. Summary written from the filing by ALFA Finder's alert engine.
Khadim India Ltd: key numbers
- Share price
- ₹123.76
- Market cap
- ₹227.4 Cr
- Revenue (annual)
- ₹367.1 Cr
- Net profit (annual)
- ₹3.10 Cr
- P/E (TTM)
- 82.1×Sector 62.3×
- Promoter holding
- 59.89%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Khadim India Ltd
All →Khadim India Board Meeting Date
Khadim India has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The notice is advance intimation, with no results disclosed yet.
Khadim India Convertible Warrants
Khadim India Ltd reported the allotment of 10,22,727 fully convertible equity warrants to promoter and non-promoter categories after receiving 25% consideration.
Khadim India Capital Structure Change
Director Pankaj Prasoon acquired 5,14,355 Khadim India equity shares via open market on 14 Oct 2024, taking combined holding with PACs to 6.16%. No acquisition price is disclosed in the filing.
Khadim India Capital Structure Change
Khadim India allotted 10.22 lakh warrants on a preferential basis, including 2.27 lakh to promoter Siddhartha Roy Burman at Rs. 110 each.
- Value
- ₹0.63 Cr
Khadim India Credit Rating
CARE Ratings reaffirmed the bank facilities rating for Khadim India Limited, while revising the outlook on long-term facilities to Negative.
Khadim India Capital Structure Change
Khadim India Ltd has allotted 10,22,727 convertible warrants at ₹110 each, raising ₹11.25 Crore. This issuance follows the preferential allotment approval process.
- Value
- ₹11.25 Cr
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.